- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Proteome Sciences PLC (PRM)
Proteome Sciences PLC stock price live, this page displays LON PRM stock exchange data. View the PRM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Proteome Sciences PLC real time stock price chart below.
What Is the Proteome Sciences PLC Stock Price Today?
The Proteome Sciences PLC stock price today is 3.36.
What Is the Stock Symbol for Proteome Sciences PLC?
The stock symbol for Proteome Sciences PLC is "PRM."
What Stock Exchange Does Proteome Sciences PLC Trade On?
Proteome Sciences PLC is listed and trades on the London stock exchange.
Is Proteome Sciences PLC a Good Stock to Buy?
Determining whether Proteome Sciences PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRM quote. (ISIN: GB0003104196)
What Is the Proteome Sciences PLC Stock Price Today?
The Proteome Sciences PLC stock price today is 3.36.
What Is the Stock Symbol for Proteome Sciences PLC?
The stock symbol for Proteome Sciences PLC is "PRM."
What Stock Exchange Does Proteome Sciences PLC Trade On?
Proteome Sciences PLC is listed and trades on the London stock exchange.
Is Proteome Sciences PLC a Good Stock to Buy?
Determining whether Proteome Sciences PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRM quote. (ISIN: GB0003104196)
3.36
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.36
3.36
52 wk Range
2.30
5.40
PRM Scorecard
Full Analysis
Operates with a significant debt burden
PRM is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.363.36
52 wk Range
2.305.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PRM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Proteome Sciences PLC Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Compare PRM to Peers and Sector
Metrics to compare | PRM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | −8.0x | −0.5x | |
PEG Ratio | 0.08 | −0.04 | 0.00 | |
Price/Book | −1.5x | 2.9x | 2.6x | |
Price / LTM Sales | 2.0x | 4.9x | 3.1x | |
Upside (Analyst Target) | - | 55.0% | 48.3% | |
Fair Value Upside | Unlock | 13.0% | 7.6% | Unlock |
Earnings
Latest Release
Apr 10, 2025
EPS / Forecast
-- / --
Revenue / Forecast
2.67M / --
FAQ
What Is the Proteome (PRM) Stock Price Today?
The Proteome stock price today is 3.36
What Stock Exchange Does Proteome Trade On?
Proteome is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Proteome?
The stock symbol for Proteome is "PRM."
What Is the Proteome Market Cap?
As of today, Proteome market cap is 9.92M.
What Is Proteome's Earnings Per Share (TTM)?
The Proteome EPS (TTM) is -0.01.
When Is the Next Proteome Earnings Date?
Proteome will release its next earnings report on 17 Aug 2025.
From a Technical Analysis Perspective, Is PRM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Proteome Stock Split?
Proteome has split 1 times.
How Many Employees Does Proteome Have?
Proteome has 36 employees.
What is the current trading status of Proteome (PRM)?
As of 13 Jun 2025, Proteome (PRM) is trading at a price of 3.36, with a previous close of 3.36. The stock has fluctuated within a day range of 3.36 to 3.36, while its 52-week range spans from 2.30 to 5.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.